[1]潘国刚,杨碧秀.鼻咽癌不同临床分期中白细胞介素水平表达的最新研究进展[J].现代检验医学杂志,2021,36(05):184-188.[doi:10.3969/j.issn.1671-7414.2021.05.040]
 PAN Guo-gang,YANG Bi-xiu.Latest Research Progress on the Expression Mechanism of Interleukin inNasopharyngeal Carcinoma Different Clinical Staging[J].Journal of Modern Laboratory Medicine,2021,36(05):184-188.[doi:10.3969/j.issn.1671-7414.2021.05.040]
点击复制

鼻咽癌不同临床分期中白细胞介素水平表达的最新研究进展()
分享到:

《现代检验医学杂志》[ISSN:/CN:]

卷:
第36卷
期数:
2021年05期
页码:
184-188
栏目:
综 述
出版日期:
2021-10-14

文章信息/Info

Title:
Latest Research Progress on the Expression Mechanism of Interleukin inNasopharyngeal Carcinoma Different Clinical Staging
文章编号:
1671-7414(2021)05-184-05
作者:
潘国刚杨碧秀
(右江民族医学院附属医院,广西百色 533000)
Author(s):
PAN Guo-gang YANG Bi-xiu
(Affiliated Hospital of Youjiang Medical College for Nationalities, Guangxi Baise 533000, China)
关键词:
白细胞介素鼻咽癌临床分期治疗
分类号:
R739.63;R730.43
DOI:
10.3969/j.issn.1671-7414.2021.05.040
文献标志码:
A
摘要:
鼻咽癌(nasopharyngeal carcinoma,NPC)是我国常见的头颈部恶性肿瘤,临床上常用放化疗来针对治疗,但已到瓶颈期,由此针对鼻咽癌不同临床分期表达机制的研究越来越受到关注,以便发现新的疾病治疗机制。而细胞因子白细胞介素(interleukin,IL)与鼻咽癌发生、发展以及其不同临床分期表达机制存在一定的相关性,但是缺乏系统和全面的研究总结,该文拟对白细胞介素在鼻咽癌不同临床分期中的表达机制进行综述。
Abstract:
Nasopharyngeal carcinoma (NPC) is a common head and neck nausea tumor in China. Radiotherapy and chemotherapyare commonly used to treat nasopharyngeal carcinoma, but it has reached the bottleneck stage. Therefore, more and moreattention has been paid to the research on the expression mechanism of different clinical NPC stage in order to find new treatmentmechanism of the disease. And cytokine interleukin (IL) and different clinical NPC development and its expression mechanismhas certain correlation in stages, but the lack of systematic and comprehensive research summary. This article intends to reviewthe expression mechanism of interleukins in different clinical stages of nasopharyngeal carcinoma.

参考文献/References:

[1] SECOMBES C J, WANG Tiehui, BIRD S. The interleukinsof fish[J]. Developmental and ComparativeImmunology, 2011, 35(12): 1336-1345.
[2] BUCKLEY L F, VISCUSI M M, VAN TASSELL BW, et al. Interleukin-1 blockade for the treatment ofpericarditis[J]. European Heart Journal-CardiovascularPharmacotherapy, 2018, 4(1): 46-53.
[3] BRODZIKOWSKA A, G?RSKA R, KOWALSKI J.Interleukin-1 genotype in periodontitis[J]. ArchivumImmunologiae et Therapiae Experimentalis, 2019,67(6): 367-373.
[4] DINARELLO C A. Overview of the IL-1 familyin innate inflammation and acquired immunity[J].Immunological Reviews, 2018, 281(1): 8-27.
[5] MOORLAG S, R?RING R J, JOOSTEN L, et al. Therole of the interleukin-1 family in trained immunity[J].Immunological Reviews, 2018, 281(1): 28-39.
[6] WRANGLE J M, PATTERSON A, JOHNSON C B,et al. IL-2 and beyond in cancer immunotherapy[J].Journal of Interferon & Cytokine Research ,2018,38(2): 45-68.
[7] KIRCHHOFF D, STELTE-LUDWIG B, LERCHENH G, et al. IL3RA-Targeting antibody-drug conjugateBAY-943 with a kinesin spindle protein inhibitorpayload shows efficacy in preclinical models ofhematologic malignancies[J]. Cancers, 2020, 12(11):3464.
[8] NAGASE H, UEKI S, FUJIEDA S. The roles ofIL-5 and anti-IL-5 treatment in eosinophilic diseases:Asthma, eosinophilic granulomatosis with polyangiitis,and eosinophilic chronic rhinosinusitis[J]. AllergologyInternational, 2020, 69(2): 178-186.
[9] TANAKA T, NARAZAKI M, INTERLEUKIN KT. (IL-6)immunotherapy[J]. Cold Spring HarborPerspectives in Biology, 2018, 10(8): a028456.
[10] ROSE-JOHN S. Interleukin-6 family cytokines[J]. ColdSpring Harbor Perspectives in Biology, 2018, 10(2):a028415.
[11] HASEGAWA H, MIZOGUCHI I, CHIBA Y, et al.Expanding diversity in molecular structures andfunctions of the IL-6/IL-12 heterodimeric cytokinefamily[J]. Frontiers in Immunology, 2016, 7(8): 479.
[12] WEI Huaxing, LI Bofeng, SUN Anyuan,et al.Interleukin-10 family cytokines immunobiology andstructure.[J]. Advances in Experimental Medicine andBiology, 2019, 1172:79-96.
[13] NEUMANN C, SCHEFFOLD A, RUTZ S. Functionsand regulation of T cell-derived interleukin-10[J].Seminars in Immunology, 2019, 44(3): 101344.
[14] BURMEISTER A R, MARRIOTT I. The interleukin-10family of cytokines and their role in the CNS[J].Frontiers in Cellular Neuroscience, 2018, 12: 458.
[15] 崔冉,许小娟,周玲玲,等. 基质金属蛋白酶-10与内分泌代谢疾病的相关性[J]. 中华骨质疏松和骨矿盐疾病杂志,2019,12(4):388-394.CUI Ran, XU Xiaojuan, ZHOU Lingling, et al.Correlation between matrix metalloproteinase -10and endocrine metabolism disorders [J]. ChineseJournal of Osteoporosis and Bone Mineral Research,2019,12(4):388-394.
[16] MONIN L, GAFFEN S L. Interleukin 17 familycytokines: signaling mechanisms, biological activities,and therapeutic implications[J]. Cold Spring HarborPerspectives in Biology, 2018, 10(4): a028522.
[17] 郭蕊,马骏.鼻咽癌分期的演变与未来发展[J]. 中国癌症防治杂志 ,2020,12(4):370-376.GUO Rui, MA Jun. Evolution and future developmentof stage of nasopharyngeal carcinoma [J].Chinese Journal of Oncology Prevention and Treatment,2020,12(4):370-376.
[18] 宗井凤, 许元基, 潘建基. 鼻咽癌分期研究进展[J].中国癌症防治杂志,2017,9(4):247-250.ZONG Jingfeng, XU Yuanji, PAN Jianji. Progressin staging of nasopharyngeal carcinoma[J]. ChineseJournal of Oncology Prevention and Treatment, 2017,9(4): 247-250.
[19] MENSSEN H D, HARNACK U, ERBEN U, et al.Antibody-based delivery of tumor necrosis factor(L19-TNFα) and interleukin-2 (L19-IL2) to tumorassociatedblood vessels has potent immunologicaland anticancer activity in the syngeneic J558L BALB/c myeloma model[J]. Journal of Cancer Research andClinical Oncology, 2018, 144(3): 499-507.
[20] WANG Xiwei, XIANG Zheng, TSAO G S W, et al.Exosomes derived from nasopharyngeal carcinomacells induce IL-6 production from macrophages topromote tumorigenesis[J]. Cellular & MolecularImmunology, 2021, 18(2): 501-503.
[21] KONG Yonggang, CUI Min, CHEN Shiming, et al.LncRNA-LINC00460 facilitates nasopharyngealcarcinoma tumorigenesis through sponging miR-149-5p to up-regulate IL6[J]. Gene, 2018, 639: 77-84.
[22] HUANG Chungyu, CHANG W S, TSAI C W, et al. Thecontribution of interleukin-8 genotypes and expressionto nasopharyngeal cancer susceptibility in Taiwan[J].Medicine, 2018, 97(36): e12135.
[23] SUNDERLAND P, AUGUSTYNIAK J, LENART J, etal. ATM-deficient neural precursors develop senescencephenotype with disturbances in autophagy[J]. Mechanismsof Ageing and Development,2020, 190(9):111296
[24] 蔡朝阳. 基质金属蛋白酶9 和白介素8 在鼻咽癌中的表达及其与潜伏膜蛋白1 的相关性研究[D].杭州:浙江大学,2007.CAI Chaoyang. Expression of matrix metalloprotein-ase-9 and interleukin-8 in nasopharyngeal carcinomaand relationship with Epstein-Barr virus latent membraneprotein-1 [D]. Hangzhou:Zhejiang University,2007.
[25] NALBANT A, SAYGILI T. IL12, IL10, IFNγ andTNFα expression in human primary monocytesstimulated with bacterial heat shock GroEL (Hsp64)protein[J]. PLoS One, 2016, 11(4): e0154085.
[26] ZHAO Xin, LIU Jinyu, GE Shasha, et al. Saikosaponina inhibits breast cancer by regulating Th1/Th2balance[J]. Frontiers in Pharmacology, 2019, 10: 624.
[27] 黄珊,劳小霞,秦雪,等. 白介素-16 基因多态性与广西地区鼻咽癌遗传易感性的研究[J].重庆医学,2012,41(3):220-223, 226.HUANG Shan, LAO Xiaoxia, QIN Xue, et al. Associationbetween polymorphisms of interleukin-16 gene andsusceptibility to nasopharyngeal carcinoma in Guangxi[J]. Chongqing Medicine,2012,41(3):220-223,226.
[28] 胡梅,周芳亮,宋岚,等. 益气解毒颗粒协同顺铂对鼻咽癌移植瘤干预及调节Foxp3/ROR-γt 平衡的作用[J]. 中草药,2019,50(9):2121-2126.HU Mei, ZHOU Fangliang, SONG Lan, et al. Effect ofQi-Boosting Toxin-Resolving Granules and cisplatin ontransplanted tumor of nasopharyngeal carcinoma andbalance of Foxp3/ROR-γt [J]. Chinese Traditional andHerbal Drugs, 2019, 50 (9) : 2121-2126.
[29] 李栋才, 邱书奇, 赵海亮, 等. 白细胞介素24 对鼻咽癌CNE-2Z 细胞株增殖的影响[J]. 医学综述,2011, 17(12):1880-1882.LI Dongcai, QIU Shuqi, ZHAO Hailiang, et al. Therole of interleukin-24 on proliferation of humannasopharyngeal carcinoma(NPC) cell line CNE-2Z [J].Medical Recapitulate,2011,17(12):1880-1882.
[30] 高艳丽,苏影.IL27RA 对EBV 感染的鼻咽癌细胞TRAF1/2 表达的调控及其生物学效应[J].病毒学报,2020,36(2):262-269.GAO Yanli, SU Ying. Regulation on TRAF1/2 expressionand biological effect of IL27RA in NPCcells with EBV [J]. Chinese Journal of Virology,2020,36(2):262-269.
[31] XU Rong, SHEARS R K, SHARMA R, et al. IL-35 iscritical in suppressing superantigenic Staphylococcusaureus-driven inflammatory Th17 responses in humannasopharynx-associated lymphoid tissue.[J]. MucosalImmunology, 2020, 13(3):460-470.
[32] 宫榭阳, 徐鹏, 葛长宇, 等.IL-6 在卵巢癌中的研究进展[J]. 中华全科医学,2019,17(3):455-458.GONG Xieyang, XU Peng, GE Changyu, et al.Research progress on IL-6 in ovarian cancer [J].Chinese Journal of General Practice, 2019,17 (3): 455-458.
[33] 胡鑫,董明豪,乔师师.炎症在胰腺癌中的作用及研究进展[J]. 河南外科学杂志,2018,24(2):156-159.HU Xin, DONG Minghao, QIAO Shishi. The role andresearch progress of inflammation in pancreatic cancer[J]. Henan Journal of Surgery, 2018,24 (2): 156-159.
[34] AMATYA N, GARG A V, GAFFEN S L. IL-17 signaling:the yin and the yang[J]. Trends in Immunology,2017, 38(5): 310-322.
[35] 戴春. 细胞因子与肺癌关系的研究进展[J]. 医学理论与实践,2017,30(17):2531-2533,2536.DAI Chun. Research progress on the relationshipbetween cytokines and lung cancer [J]. the Journalof Medical Theory and Practice, 2017,30 (17): 2531-2533,2536.
[36] TANG Linglong, CHEN Yupei, MAO Yanping, etal. Validation of the 8th edition of the UICC/AJCCstaging system for nasopharyngeal carcinoma fromendemic areas in the Intensity-Modulated radiotherapyera[J]. Journal of the National Comprehensive CancerNetwork, 2017, 15(7): 913-919.

相似文献/References:

[1]吉翔,华芸,张学军.哮喘患儿血清白介素与免疫球蛋白检测的临床意义[J].现代检验医学杂志,2015,30(06):127.[doi:10.3969/j.issn.1671-7414.2015.06.039]
 JI Xiang,HUA Yun,ZHANG Xue-jun.Clinical Significance of Combined Detection of Serum Interleukin and Immune Globulin in Children with Asthma[J].Journal of Modern Laboratory Medicine,2015,30(05):127.[doi:10.3969/j.issn.1671-7414.2015.06.039]
[2]李 璐,梁 辉a,陈群蓉b.鼻咽癌组织中SYK基因启动子区的甲基化分析[J].现代检验医学杂志,2015,30(02):39.[doi:10.3969/j.issn.1671-7414.2015.02.012]
 LI Lu,LIANG Huia,CHEN Qun-rongb.Methylation of SYK Gene Promoter Region in Nasopharyngeal Carcinoma[J].Journal of Modern Laboratory Medicine,2015,30(05):39.[doi:10.3969/j.issn.1671-7414.2015.02.012]
[3]彭玉凤,张扬南,黄常洪,等.鼻咽癌患者血清同型半胱氨酸水平与临床病理特征的相关性分析[J].现代检验医学杂志,2019,34(02):115.[doi:10.3969/j.issn.1671-7414.2019.02.029]
 PENG Yu-feng,ZHANG Yang-nan,HUANG Chang-hong,et al.Correlation Analysis between Serum Homocysteine Level ofNasopharyngeal Carcinoma Patients and Clinical Pathological Features[J].Journal of Modern Laboratory Medicine,2019,34(05):115.[doi:10.3969/j.issn.1671-7414.2019.02.029]
[4]张玲,刘杰,王臣玉,等.EB 病毒Rta 优势表位抗原的克隆表达及在应用ELISA 诊断鼻咽癌中的价值[J].现代检验医学杂志,2020,35(05):1.[doi:10.3969/j.issn.1671-7414.2020.05.001]
 ZHANG Ling,LIU Jie,WANG Chen-yu,et al.Cloning and Expression of Dominant Epitope Antigen of Epstein-Barr Virus Rta Protein and Its Application in the Diagnosis of Nasopharyngeal Carcinoma by ELISA[J].Journal of Modern Laboratory Medicine,2020,35(05):1.[doi:10.3969/j.issn.1671-7414.2020.05.001]
[5]薛玉峰a,张会平a,王 芳b,等.鼻咽癌患者血清miR-144-3p及miR-151-3p的表达水平及临床价值[J].现代检验医学杂志,2021,36(05):65.[doi:10.3969/j.issn.1671-7414.2021.05.015]
 XUE Yu-fenga,ZHANG Hui-pinga,WANG Fangb,et al.Expression and Clinical Value of Serum miR-144-3p and miR-151-3pLevels in Patients with Nasopharyngeal Carcinoma[J].Journal of Modern Laboratory Medicine,2021,36(05):65.[doi:10.3969/j.issn.1671-7414.2021.05.015]
[6]胡鹏刚,张昌明.枸杞皂苷通过调控Suv39H1/JAK2/STAT3通路对鼻咽癌细胞增殖、侵袭和凋亡的影响[J].现代检验医学杂志,2021,36(06):27.[doi:10.3969/j.issn.1671-7414.2021.06.006]
 HU Peng-gang,ZHANG Chang-ming.Lycium Barbarum Saponins Affect Proliferation, Invasion and Apoptosis of Nasopharyngeal Carcinoma Cells by Regulating the Suv39H1/JAK2/STAT3 Pathway[J].Journal of Modern Laboratory Medicine,2021,36(05):27.[doi:10.3969/j.issn.1671-7414.2021.06.006]
[7]崔普芳,龚 源,刘爱胜,等.深圳地区妊娠期子痫前期孕妇血清中IL-22,IL-17,IL-10,TGF-β水平表达及IL-22基因rs2227485T/C位点多态性分析[J].现代检验医学杂志,2021,36(06):55.[doi:10.3969/j.issn.1671-7414.2021.06.011]
 CUI Pu-fang,GONG Yuan,LIU Ai-sheng,et al.Expression of Serum Levels of IL-22, IL-17, IL-10 and TGF-β in Pregnant Women with Preeclampsia During Pregnancy and Polymorphism Analysis of IL-22 Gene rs2227485 T/C Locus in Shenzhen Area[J].Journal of Modern Laboratory Medicine,2021,36(05):55.[doi:10.3969/j.issn.1671-7414.2021.06.011]
[8]姜永滨,任东铭,隋成君.下肢动脉硬化闭塞症患者血清IL-17 和TNF-α 水平表达及其临床意义[J].现代检验医学杂志,2022,37(05):168.[doi:10.3969/j.issn.1671-7414.2022.05.033]
 JIANG Yong-bin,REN Dong-ming,SUI Cheng-jun.Expression and Clinical Significance of Serum Levels of IL-17 and TNF-α in Patients with Arteriosclerosis Obliterans of Lower Extremity[J].Journal of Modern Laboratory Medicine,2022,37(05):168.[doi:10.3969/j.issn.1671-7414.2022.05.033]
[9]顾刘雷a,顾 培b,金广浩a,等.鼻咽癌组织中LncRNA CTBP1-AS2 和miR-140-5p 水平表达与放疗疗效及预后的关系研究[J].现代检验医学杂志,2024,39(02):23.[doi:10.3969/j.issn.1671-7414.2024.02.005]
 GU Liuleia,GU Peib,JIN Guanghaoa,et al.Relationship between the Expression of LncRNA CTBP1-AS2 and miR-140-5p Levels in Nasopharyngeal Carcinoma Tissues and Radiotherapeutic Effect and Prognosis[J].Journal of Modern Laboratory Medicine,2024,39(05):23.[doi:10.3969/j.issn.1671-7414.2024.02.005]

备注/Memo

备注/Memo:
作者简介:潘国刚(1973-),男,本科,副主任技师,研究方向:临床医学检验分子细胞学和生化检验学,E-mail:wangwang715716@163.com。
更新日期/Last Update: 1900-01-01